BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Merck & Co. (MRK) And BioImage A/S Sign Licensing Deal On Redistribution(R) Technology


10/19/2005 5:10:06 PM

COPENHAGEN, Denmark, September 13 /PRNewswire/ -- BioImage A/S, Denmark, today announced that it has signed a licensing agreement with Merck & Co, Inc. granting Merck the freedom to use BioImage's Redistribution(R) technology in its drug discovery research. Financial terms were not disclosed.

The Redistribution(R) patent portfolio covers a broad range of methods aimed at studying intracellular signalling events. The Redistribution(R) technology enables high throughput screening on a number of drug discovery live cell screening applications, such as protein translocations, receptor internalizations, protein trafficking, secretions, etc. BioImage is presently out licensing the portfolio to a number of leading companies within the life science industry.

"We are delighted and proud to have a world class pharmaceutical company like Merck license our patent portfolio", said Dr. Patrik Dahlen, CEO of BioImage. "By using the Redistribution(R) technology, researchers can track proteins in living cells and screen for compounds that affect specific cellular signalling pathways. This improves the biological relevance of drug screening and helps increase the speed and accuracy of drug discovery and development. At BioImage, we have developed an extensive experience in the area of protein translocation assays and pathway screening."

Notes for Editors:

BioImage A/S is a drug discovery company based in Copenhagen focusing on cell-based pathway screening for the identification of new therapeutics. The Company has drug discovery projects in inflammation and oncology disease areas. BioImage's approach to drug discovery monitors protein translocation in living cells - we call it Redistribution(R) - as the primary assay readout. BioImage tracks protein translocation with relevant targets that are tagged with Green Fluorescent Protein (GFP); this allows BioImage to optimize the use of GFP to develop unique drug discovery screening technology. BioImage has an extensive patent portfolio covering the concept of Redistribution(R). BioImage is also out licensing the portfolio to a number of leading companies within the life science industry including, Bristol Myers Squibb, Eli Lilly and Merck & Co.

BioImage employs approximately 40 people at its research facility in Copenhagen, at the center of Medicon Valley. The company is financially backed by leading international investors including, Apax Partners, Abingworth Management Ltd and Novo A/S.

For more information please visit http://www.bioimage.com/.

BioImage A/S

CONTACT: Contacts: Ulrik Vejlsgaard, Chief Operating Officer, BioImageA/S, Moerkhoej Bygade 28, DK-2860 Soeborg, Denmark, Tel:+45-44-43-34-44 Fax: +45-44-43-75-05 E-mail:ulrik.vejlsgaard@bioimage.com Web: http://www.bioimage.com/ MediaEnquiries: Eileen Paul, Northbank Communications, Tel:+44-(0)-1260-296500 Fax: +44-(0) 1260-296501 E-mail:e.paul@northbankcommunications.com Web:http://www.northbankcommunications.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES